Related Experiment Video
Updated: May 8, 2026
Viral Nanoparticles for In vivo Tumor Imaging
Published on: November 16, 2012
Mitochondria-Targeting Virus-Like Gold Nanoparticles Enhance Chemophototherapeutic Efficacy Against Pancreatic Cancer
Youshuai Meng1, Chuan Chen1,2, Ronggui Lin1,3
1Key Laboratory of Nanomedical Technology (Education Department of Fujian Province), Department of Pharmaceutical Analysis, School of Pharmacy, Fujian Medical University, Fuzhou, 350122, People's Republic of China.
Background:
The dense and fibrotic nature of the pancreatic tumor microenvironment significantly contributes to tumor invasion and metastasis. This challenging environment acts as a formidable barrier, hindering effective drug penetration and delivery, which ultimately limits the efficacy of conventional cancer treatments. Gold nanoparticles (AuNPs) have emerged as promising nanocarriers to overcome the extracellular matrix barrier; however, their limited targeting precision, poor delivery efficiency, and insufficient photothermal conversion present challenges.
Methods:
We developed triphenyl phosphonium-functionalized high-branch gold nanoparticles, denoted as Dox@TPAu, to enhance drug delivery and targeting capabilities. The targeted penetration, biopharmaceutical and pharmacokinetic properties of Dox@TPAu were characterized, and the synergistic therapeutic effect was evaluated by the BxPC-3 xenograft tumor mouse model.
Results:
Dox@TPAu exhibits superior photothermal conversion efficiency (91.0%) alongside a high drug loading efficiency (26%) and effective photo-triggered drug-release potential. This Dox@TPAu drug delivery system adeptly accumulates at tumor sites due to its unique properties, enabling targeted localization within cancer cells and the mitochondria of stromal fibroblasts. This localization disrupts mitochondrial function and transfer-processes crucial for energy production, metabolism, and cell signaling within the tumor microenvironment. Pharmacokinetic analyses revealed an optimal spatiotemporal distribution of Dox@TPAu at the tumor site. This strategic accumulation enables precise disruption of both the physical barrier and cancer cells, enhancing treatment efficacy through near-infrared light-triggered local chemo-photothermal synergistic therapy.
Conclusion:
Our findings demonstrate that this innovative strategy effectively leverages the unique properties of mitochondria-targeting, virus-like AuNPs for precise and efficient stromal depletion, presenting a promising approach to enhance the efficacy of pancreatic cancer treatment.
Insights
This study introduces Dox@TPAu, a novel gold nanoparticle system that enhances drug delivery for pancreatic cancer. It effectively targets tumor microenvironments and improves chemo-photothermal therapy efficacy.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Pancreatic tumor microenvironment is dense and fibrotic, hindering drug delivery and treatment efficacy.
- Conventional therapies face challenges due to poor drug penetration and targeting precision.
- Gold nanoparticles (AuNPs) show promise but require improved targeting and efficiency.
Purpose of the Study:
- To develop and evaluate triphenyl phosphonium-functionalized high-branch gold nanoparticles (Dox@TPAu) for enhanced pancreatic cancer drug delivery and targeting.
- To assess the synergistic therapeutic effect of Dox@TPAu in a preclinical pancreatic cancer model.
Main Methods:
- Development of Dox@TPAu nanoparticles functionalized with triphenyl phosphonium.
- Characterization of Dox@TPAu's penetration, biopharmaceutical, and pharmacokinetic properties.
- Evaluation of synergistic chemo-photothermal therapy in a BxPC-3 xenograft tumor mouse model.
Main Results:
- Dox@TPAu demonstrated high photothermal conversion efficiency (91.0%) and drug loading (26%).
- The system achieved targeted accumulation in tumor sites, localizing to cancer cells and stromal fibroblast mitochondria.
- Disruption of mitochondrial function and enhanced chemo-photothermal therapy efficacy were observed.
Conclusions:
- Mitochondria-targeting, virus-like AuNPs (Dox@TPAu) offer a precise approach for stromal depletion in pancreatic cancer.
- This strategy enhances treatment efficacy by overcoming the physical barrier and targeting cancer cells.
- Dox@TPAu presents a promising therapeutic strategy for improving pancreatic cancer treatment outcomes.
